Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene

被引：6
|
作者：
Li, Rong [1 ]
Baskfield, Amanda [1 ]
Beers, Jeanette [2 ]
Zou, Jizhong [2 ]
Liu, Chengyu [3 ]
Almeciga-Diaz, Carlos J. [4 ]
Zheng, Wei [1 ]
机构：
[1] NIH, Natl Ctr Advancing Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA
[2] NHLBI, iPSC Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Pontificia Univ Javeriana, Fac Sci, Inst Study Inborn Errors Metab, Cra 7 43-82 Lab,305A Edificio 54, Bogota, Colombia
来源：
STEM CELL RESEARCH | 2019年 / 36卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.scr.2019.101408
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Mucopolysaccharidosis type IVA (MPS IVA) is a rare genetic disease caused by mutations in the GALNS gene and is inherited in an autosomal recessive manner. GALNS encodes N-acetylgalactosamine-6-sulfatase that breaks down certain complex carbohydrates known as glycosaminoglycans (GAGs). Deficiency in this enzyme causes accumulation of GAGs in lysosomes of body tissues. A human induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts of a MPS IVA patient that has compound heterozygous mutations (p.R61W and p.WT405del) in the GALNS gene. This iPSC line offers a useful resource to study the disease pathophysiology and a cell-based model for drug development.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene
    Azevedo, Carla
    Chumarina, Margarita
    Serafimova, Evgenija
    Goldwurm, Stefano
    Collin, Anna
    Roybon, Laurent
    Savchenko, Ekaterina
    Pomeshchik, Yuriy
    STEM CELL RESEARCH, 2020, 43
  • [22] Generation and characterization of an induced pluripotent stem cell line SDQLCHi018-A from a congenital myasthenic syndrome patient carrying compound heterozygote mutations in RAPSN gene
    Zhang, Haiyan
    Zhang, Huawei
    Ma, Yanyan
    Lv, Yuqiang
    Gai, Zhongtao
    Liu, Yi
    STEM CELL RESEARCH, 2021, 51
  • [23] Establishment of induced pluripotent stem cell line CSUASOi003-A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene
    Zhou, Yalan
    Ding, Chengcheng
    Xia, Shutao
    Jing, Yutong
    Mao, Shengru
    Liu, Jian
    Chen, Juan
    Chan, Hon Fai
    Tang, Shibo
    Chen, Jiansu
    STEM CELL RESEARCH, 2020, 44
  • [24] Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene
    Wang, Xianming
    Chen, Shen
    Burtscher, Ingo
    Sterr, Michael
    Hieronimus, Anja
    Machicao, Fausto
    Staiger, Harald
    Haering, Hans-Ulrich
    Lederer, Gabriele
    Meitinger, Thomas
    Lickert, Heiko
    STEM CELL RESEARCH, 2016, 17 (02) : 273 - 276
  • [25] Generation of an induced pluripotent stem cell line SJTUXHi001-A from an autism spectrum disorder patient carrying a heterozygous mutation in HDAC8 (p.P359S)
    Chen, Zilin
    Lv, Hui
    Yu, Juehua
    Fang, Shuanfeng
    Li, Fei
    STEM CELL RESEARCH, 2022, 61
  • [26] Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T>A) mutation in JAGGED-1
    Brooks, Brianna M.
    Pradhan, Manisha
    Cheng, Yu-Shan
    Gorshkov, Kirill
    Farkhondeh, Atena
    Chen, Catherine Z.
    Beers, Jeanette
    Liu, Chengyu
    Baumgaertel, Karsten
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2021, 54
  • [27] Generation of the induced pluripotent stem cell line (ZSPHARi001-A) from a patient with recessive dystrophic epidermolysis bullosa carrying compound heterozygous mutation in the COL7A1 gene
    Zhang, Yeye
    Fan, Jun
    Lu, Guangzhao
    Xu, Genying
    Lv, Qianzhou
    STEM CELL RESEARCH, 2022, 60
  • [28] Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
    Gustavsson, Nadja
    Marote, Ana
    Pomeshchik, Yuriy
    Russ, Kaspar
    Azevedo, Carla
    Chumarina, Margarita
    Goldwurm, Stefano
    Collin, Anna
    Pinto, Luisa
    Salgado, Antonio J.
    Klementieva, Oxana
    Roybon, Laurent
    Savchenko, Ekaterina
    STEM CELL RESEARCH, 2019, 34
  • [29] Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene
    Kondrateva, Ekaterina
    Panchuk, Irina
    Demchenko, Anna
    Grigorieva, Olga
    Zheglo, Diana
    Voronina, Ekaterina
    Erofeeva, Anastasija
    Tabakov, Vyacheslav
    Orlova, Maria
    Lavrov, Alexander
    Smirnikhina, Svetlana
    Kutsev, Sergey
    STEM CELL RESEARCH, 2022, 63
  • [30] Generation of an induced pluripotent stem cell line (SDQLCHi003-a) from a patient with short rib-thoracic dysplasia syndrome type III carrying compound heterozygous mutations in DYNC2H1
    Zhang, Haiyan
    Ma, Yanyan
    Song, Fengling
    Yang, Xiaomeng
    Li, Yue
    Guan, Jingyun
    Lv, Yuqiang
    Gao, Min
    Ma, Jian
    Liu, Yi
    Gai, Zhongtao
    STEM CELL RESEARCH, 2019, 39
12345